News & Analysis on Clinical Trial Services & Contract Research And Development
The US Food and Drug Administration (FDA) approved 15 New Molecular Entities in the current year to 30 September, 2003, setting the stage to outpace last year's registrations by nearly 20 per cent, says a report from Cutting Edge Information.
Porvair Sciences of the UK has introduced a new product for concentrating samples in 96 or 384-well microplates, which aims to remove the traditional laboratory bottleneck of waiting for solvent to evaporate from the plates before further analysis.
Friedrich von Bohlen, the chief executive of German company LION bioscience, has decided to step down at the end of the year.
The number of shots delivered in national influenza immunisation programmes could be increased - without making any additional vaccine - by simply using a syringe developed by Becton Dickinson.
Two US companies have forged an alliance to develop a polymer-based technology that could be used to shield drugs from inactivating processes in the body, extending their time in the circulation.
French pharmaceutical company Sanofi-Synthelabo has opened a new manufacturing facility in Aquitaine for the production of two of its top drugs, the antithrombotic Plavix (clopidogrel) and Aprovel (irbesartan) for hypertension.
Mark McClellan, the US Food and Drug Administration Commissioner, has given the strongest hint to date that generic versions of biological drugs may be approved without the need for extensive clinical trials.
Welsh company Great Lakes Fine Chemicals has teamed up with Phoenix Chemicals to develop new, more cost effective processes for the production of pharmaceutical intermediates.
The European Court of Justice has ruled that Internet sales of prescription drugs should not be permitted in European Union member states but that over-the-counter drugs may be sold on-line and through mail-order.
Preliminary findings of a study in monkeys suggest that researchers have taken an important step towards a possible treatment strategy for the Ebola virus.